Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension

Author:

He Jianxing,Ying Weiqiang,Yang Haihong,Xu Xin,Shao Wenlong,Guan Yubao,Jiang Mei,Wu Yizhuang,Zhong Baoliang,Wang Daoyuan,Tucker Steven,Zhong Nanshan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference29 articles.

1. Estimates of cancer incidence in China for 2000 and projections for 2005;Yang;Cancer Epidemiol Biomarkers Prev,2005

2. Revisions in the International System for Staging Lung Cancer;Mountain;Chest,1997

3. Synergistic interaction between cisplatin and gemcitabine in vitro;Bergman;Clin Cancer Res,1996

4. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic nonsmall-cell lung cancer;Cardenal;J Clin Oncol,1999

5. Gemcitabine and cisplatin versus mitomycin, ifosfamide and cisplatin in advanced nonsmall-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project;Crino;J Clin Oncol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3